1Nelson HS. Immunotherapy for inhalant allergens [M]. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al. Middleton's Allergy Principles and Practice. 6th ed. Philadelphia: Mosby, 2003: 1455-1473.
2Noon L. Prophylactic inoculation against hay fever [J]. Lancet, 1911, 1: 1572-1573.
3Bousquet J, Lockey R, Mailing HJ. Allergen immtmotherapy: therapeutic vaccines for allergic diseases. A WHO Position Paper [J]. J Allergy Clin Immunol, 1998, 53(Pt1): 558-562.
4Joint Task Force on Practice Parameters. Allergen irnmunotherapy: A practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology[J]. Ann Allergy Asthma Immunol, 2003, 90(1 Suppl l): 1-40.
5Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma[J]. Allergy Clin Irnmunol, 2009, 123(4): 763-769.
6Juniper EF, Guyatt GH. Development and testing of a new measure of health staus for clinic trials in rhinoconjunctivits [J]. Clin Exp Allergy, 1991, 21(1): 77-83.
7Van Metre TE, Adkinson NF Jr, Amodio FJ, et al. A comparative study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever [J]. J Allergy Clin Immunol, 1980, 66 (6): 500-513.
10Juniper EF,Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis[ J]. Clin Exp Allergy, 1991,21 ( 1 ) :77 - 83.
